{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T20:01:02Z","timestamp":1760990462753,"version":"3.37.3"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["476637\/2012-0"],"award-info":[{"award-number":["476637\/2012-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2014\/23417-7"],"award-info":[{"award-number":["2014\/23417-7"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12936-018-2615-8","type":"journal-article","created":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T09:37:16Z","timestamp":1545212236000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["In vitro antiplasmodial activity, pharmacokinetic profiles and interference in isoprenoid pathway of 2-aniline-3-hydroxy-1.4-naphthoquinone derivatives"],"prefix":"10.1186","volume":"17","author":[{"given":"Valeska S.","family":"de Sena Pereira","sequence":"first","affiliation":[]},{"given":"Fl\u00e1vio","family":"da Silva Emery","sequence":"additional","affiliation":[]},{"given":"Lis","family":"Lobo","sequence":"additional","affiliation":[]},{"given":"F\u00e1tima","family":"Nogueira","sequence":"additional","affiliation":[]},{"given":"Jonas I. N.","family":"Oliveira","sequence":"additional","affiliation":[]},{"given":"Umberto L.","family":"Fulco","sequence":"additional","affiliation":[]},{"given":"Eudenilson L.","family":"Albuquerque","sequence":"additional","affiliation":[]},{"given":"Alejandro M.","family":"Katzin","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9986-0865","authenticated-orcid":false,"given":"Valter F.","family":"de Andrade-Neto","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2018,12,19]]},"reference":[{"key":"2615_CR1","unstructured":"WHO. Global health observatory (GHO). Geneva: World Health Organization; 2014. \n                    http:\/\/www.who.int\/gho\/malaria\/en\/\n                    \n                  . Accessed 26 Oct 2014."},{"key":"2615_CR2","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1590\/S0036-46651997000200004","volume":"39","author":"AA Segurado","year":"1997","unstructured":"Segurado AA, Di Santi SM, Shiroma M. In vivo and in vitro Plasmodium falciparum resistance to chloroquine, amodiaquine and quinine in the Brazilian Amazon. Rev Inst Med Trop S\u00e3o Paulo. 1997;39:85\u201390.","journal-title":"Rev Inst Med Trop S\u00e3o Paulo"},{"key":"2615_CR3","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1186\/1475-2875-9-355","volume":"9","author":"BE Gama","year":"2010","unstructured":"Gama BE, Oliveira NKA, Souza JM, Santos F, Carvalho LJM, Melo YFC, et al. Brazilian Plasmodium falciparum isolates: investigation of candidate polymorphisms for artemisinin resistance before introduction of artemisinin-based combination therapy. Malar J. 2010;9:355.","journal-title":"Malar J"},{"key":"2615_CR4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.exppara.2014.10.002","volume":"147","author":"F Souza-Silva","year":"2014","unstructured":"Souza-Silva F, d0 Nascimento SB, Bourguignon SC, Pereira BA, Carneiro PF, da Silva WS, et al. Evidences for leishmanicidal activity of the naphthoquinone derivative epoxy-\u03b1-lapachone. Exp Parasitol. 2014;147:81\u20134.","journal-title":"Exp Parasitol"},{"key":"2615_CR5","doi-asserted-by":"publisher","first-page":"e0002012","DOI":"10.1371\/journal.pntd.0002012","volume":"7","author":"S Pieretti","year":"2013","unstructured":"Pieretti S, Haanstra JR, Mazet M, Perozzo R, Bergamini C, Prati F, et al. Naphthoquinone derivatives exert their antitrypanosomal activity via a multi-target mechanism. PLoS Negl Trop Dis. 2013;7:e0002012.","journal-title":"PLoS Negl Trop Dis"},{"key":"2615_CR6","doi-asserted-by":"publisher","first-page":"11557","DOI":"10.1021\/ja201729z","volume":"133","author":"T M\u00fcller","year":"2011","unstructured":"M\u00fcller T, Johann L, Jannack B, Br\u00fcckner M, Lanfranchi DA, Bauer H, et al. Glutathione reductase-catalyzed cascade of redox reactions to bioactivate potent antimalarial 1,4-naphthoquinones\u2014a new strategy to combat malarial parasites. J Am Chem Soc. 2011;133:11557\u201371.","journal-title":"J Am Chem Soc"},{"key":"2615_CR7","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.ejmech.2012.06.046","volume":"54","author":"H Hussain","year":"2012","unstructured":"Hussain H, Specht S, Sarite SR, Hoerauf A, Krohn K. New quinoline-5,8-dione and hydroxynaphthoquinone derivatives inhibit a chloroquine resistant Plasmodium falciparum strain. Eur J Med Chem. 2012;54:936\u201342.","journal-title":"Eur J Med Chem"},{"key":"2615_CR8","doi-asserted-by":"publisher","first-page":"6375","DOI":"10.1039\/c2ob25812a","volume":"10","author":"DA Lanfranchi","year":"2012","unstructured":"Lanfranchi DA, Cesar-Rodo E, Bertrand B, Huang HH, Day L, Johann L, et al. Synthesis and biological evaluation of 1,4-naphthoquinones and quinoline-5,8-diones as antimalarial and schistosomicidal agents. Org Biomol Chem. 2012;10:6375\u201387.","journal-title":"Org Biomol Chem"},{"key":"2615_CR9","doi-asserted-by":"publisher","first-page":"4583","DOI":"10.1016\/j.bmcl.2013.06.033","volume":"15","author":"LC Rezende","year":"2013","unstructured":"Rezende LC, Fumagalli F, Bortolin MS, Oliveira MG, de Paula MH, de Andrade-Neto VF, de Emery FS. In vivo antimalarial activity of novel 2-hydroxy-3-aniline-1,4-naphthoquinones obtained by epoxide ring-opening reaction. Bioorg Med Chem Lett. 2013;15:4583\u20136.","journal-title":"Bioorg Med Chem Lett"},{"key":"2615_CR10","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1590\/0074-0276130603","volume":"109","author":"NB Souza","year":"2014","unstructured":"Souza NB, Andrade IM, Carneiro PF, Jardim GAM, Melo IMM, Silva J\u00fanior EM, Krettli AU. Blood shizonticidal activities of phenazines and naphthoquinoidal compounds against Plasmodium falciparum in vitro and in mice malaria studies. Mem Inst Oswaldo Cruz. 2014;109:546\u201352.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"2615_CR11","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1128\/AAC.02248-12","volume":"57","author":"K Ehrhardt","year":"2013","unstructured":"Ehrhardt K, Davioud-Charvet E, Ke H, Vaidya AB, Lanzer M, Deponte M. The antimalarial activities of methylene blue and the 1,4-naphthoquinone 3-[4-(trifluoromethyl)benzyl]-menadione are not due to inhibition of the mitochondrial electron transport chain. Antimicrob Agents Chemother. 2013;57:2114\u201320.","journal-title":"Antimicrob Agents Chemother"},{"key":"2615_CR12","doi-asserted-by":"publisher","first-page":"e1001138","DOI":"10.1371\/journal.pbio.1001138","volume":"9","author":"E Yeh","year":"2011","unstructured":"Yeh E, DeRisi JL. Chemical rescue of malaria parasites lacking an apicoplast defines organelle function in blood-stage Plasmodium falciparum. PLoS Biol. 2011;9:e1001138.","journal-title":"PLoS Biol"},{"key":"2615_CR13","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1126\/science.284.5422.1961","volume":"284","author":"TM Iverson","year":"1999","unstructured":"Iverson TM, Luna-Chavez C, Cecchini G, Rees DC. Structure of the Escherichia coli fumarate reductase respiratory complex. Science. 1999;284:1961\u20136.","journal-title":"Science"},{"issue":"Suppl 1","key":"2615_CR14","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1590\/S0074-02762011000900018","volume":"106","author":"FM Jord\u00e3o","year":"2011","unstructured":"Jord\u00e3o FM, Kimura EA, Katzin AM. Isoprenoid biosynthesis in the erythrocytic stages. Mem Inst Oswaldo Cruz. 2011;106(Suppl 1):134\u201341.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"2615_CR15","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/1475-2875-12-184","volume":"12","author":"FM Jord\u00e3o","year":"2013","unstructured":"Jord\u00e3o FM, Gabriel HB, Alves JMP, Angeli CB, Bifano TD, Breda A, et al. Cloning and characterization of bifunctional enzyme farnesyl diphosphate\/geranylgeranyl diphosphate synthase from Plasmodium falciparum. Malar J. 2013;12:184.","journal-title":"Malar J"},{"key":"2615_CR16","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0163-7827(99)00008-9","volume":"38","author":"X Wang","year":"1999","unstructured":"Wang X, Quinn PJ. Vitamin E and its function in membranes. Prog Lipid Res. 1999;38:309\u201336.","journal-title":"Prog Lipid Res"},{"key":"2615_CR17","unstructured":"Minist\u00e9rio da Sa\u00fade. Resolu\u00e7\u00e3o CNS 251\/97 - Normas de pesquisa com novos f\u00e1rmacos, medicamentos, vacinas e testes diagn\u00f3sticos envolvendo seres humanos. Di\u00e1rio Oficial da Uni\u00e3o, Brasil. 1997. p. 21117."},{"key":"2615_CR18","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/90761","volume":"19","author":"J Hodgson","year":"2001","unstructured":"Hodgson J. ADMET\u2014turning chemicals into drugs. Nature. 2001;19:722\u20136. \n                    https:\/\/doi.org\/10.1038\/90761\n                    \n                  .","journal-title":"Nature"},{"key":"2615_CR19","first-page":"109","volume":"7","author":"HE Selick","year":"2002","unstructured":"Selick HE, Beresford AP, Tarbit MH. The emerging importance of predictive ADME simulation in drug discovery. Drug Discov. 2002;7:109\u201316.","journal-title":"Drug Discov"},{"key":"2615_CR20","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/nrd1156","volume":"2","author":"H Kubinyi","year":"2003","unstructured":"Kubinyi H. Drug research: myths, hype and reality. Nat Rev Drug Discov. 2003;2:665\u20138.","journal-title":"Nat Rev Drug Discov"},{"key":"2615_CR21","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1517\/17425255.2015.980814","volume":"11","author":"VG Maltarollo","year":"2015","unstructured":"Maltarollo VG, Gertrudes JC, Oliveira PR, Honorio KM. Applying machine learning techniques for ADME-Tox prediction: a review. Expert Opin Drug Metab Toxicol. 2015;11:259\u201371.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2615_CR22","volume-title":"Antitargets: prediction and prevention of drug side effects, Chapt 1","author":"D Schuster","year":"2008","unstructured":"Schuster D, Laggner C, Langer T. Why drugs fail\u2014a study on side effects in new chemical entities. In: Vaz RJ, Klabunde T, editors. Antitargets: prediction and prevention of drug side effects, Chapt 1. Weinheim: Wiley; 2008."},{"key":"2615_CR23","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrd1063","volume":"2","author":"WP Walters","year":"2003","unstructured":"Walters WP, Namchuk M. Designing screens: how to make your hits a hit. Nat Rev Drug Discov Today. 2003;2:259\u201366.","journal-title":"Nat Rev Drug Discov Today"},{"key":"2615_CR24","doi-asserted-by":"publisher","first-page":"W200","DOI":"10.1093\/nar\/gkv353","volume":"43","author":"D Lagorce","year":"2015","unstructured":"Lagorce D, Sperandio O, Baell JB, Miteva MA, Villoutreix BO. FAF-Drugs3: a web server for compound property calculation and chemical library design. Nucleic Acids Res. 2015;43:W200\u20137.","journal-title":"Nucleic Acids Res"},{"key":"2615_CR25","unstructured":"MarvinSketch. \n                    http:\/\/www.chemaxon.com\n                    \n                  ."},{"issue":"12","key":"2615_CR26","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1002\/jps.20217","volume":"93","author":"IV Tetko","year":"2004","unstructured":"Tetko IV, Bruneau P. Application of ALOGPS to predict 1-octanol\/water distribution coefficients, logP, and logD, of AstraZeneca in-house database. J Pharm Sci. 2004;93(12):3103\u201310.","journal-title":"J Pharm Sci"},{"key":"2615_CR27","unstructured":"Lee SK, Chang GS, Lee IH, Chung JE, Sung KY, No KT. The PreADME: Pc-based program for batch prediction of adme properties. In: Proceedings of the EuroQSAR, Istanbul, Turkey. 2004. pp. 5\u201310."},{"key":"2615_CR28","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1590\/S0074-02762007000300016","volume":"102","author":"VF Andrade-Neto","year":"2007","unstructured":"Andrade-Neto VF, Pohlit AM, Pinto AC, Silva ECC, Nogueira KL, Melo MRS, et al. In vitro inhibition of Plasmodium falciparum by substances isolated from Amazonian antimalarial plants. Mem Inst Oswaldo Cruz. 2007;102:359\u201365.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"2615_CR29","doi-asserted-by":"publisher","first-page":"418","DOI":"10.2307\/3280287","volume":"65","author":"C Lambros","year":"1979","unstructured":"Lambros C, Vanderberg JP. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol. 1979;65:418\u201320.","journal-title":"J Parasitol"},{"key":"2615_CR30","first-page":"1010","volume":"21","author":"M Machado","year":"2016","unstructured":"Machado M, Murtinheira F, Lobo E, Nogueira F. Whole-Cell SYBR Green I assay for antimalarial activity assessment. Ann Clin Med Microbiol. 2016;21:1010.","journal-title":"Ann Clin Med Microbiol"},{"issue":"4","key":"2615_CR31","first-page":"577","volume":"5","author":"DUO Meneguetti","year":"2014","unstructured":"Meneguetti DUO, Cunha RM, Lima RA, Oliveira FAS, Medeiros DSS, Passarini GM, et al. Antimalarial ethnopharmacology in the Brazilian Amazon. Rev Ci\u00eanc Farm B\u00e1sica Apl. 2014;5(4):577\u201387.","journal-title":"Rev Ci\u00eanc Farm B\u00e1sica Apl"},{"key":"2615_CR32","doi-asserted-by":"publisher","first-page":"3985","DOI":"10.1016\/j.febslet.2011.11.005","volume":"585","author":"RAC Sussmann","year":"2011","unstructured":"Sussmann RAC, Angeli CB, Peres VJ, Kimura EA, Katzin AM. Intraerythrocytic stages of Plasmodium falciparum biosynthesize vitamin E. FEBS Lett. 2011;585:3985\u201391.","journal-title":"FEBS Lett"},{"key":"2615_CR33","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/1475-2875-13-112","volume":"13","author":"L Mata-Cantero","year":"2014","unstructured":"Mata-Cantero L, Lafuente MJ, Sanz L, Rodriguez MS. Magnetic isolation of Plasmodium falciparum schizonts iRBCs to generate a high parasitaemia and synchronized in vitro culture. Malar J. 2014;13:112.","journal-title":"Malar J"},{"key":"2615_CR34","doi-asserted-by":"publisher","first-page":"4761","DOI":"10.1016\/j.febslet.2010.10.055","volume":"584","author":"R Tonhosolo","year":"2010","unstructured":"Tonhosolo R, Gabriel HB, Matsumura MY, Cabral FJ, Yamamoto MM, D\u2019Alexandri FL, et al. Intraerythrocytic stages of Plasmodium falciparum biosynthesize menaquinone. FEBS Lett. 2010;584:4761\u20138.","journal-title":"FEBS Lett"},{"key":"2615_CR35","unstructured":"Silva FAS, Azevedo CAV. Principal components analysis in the software assistat-statistical attendance. In: World Congress on Computers in Agriculture, 7, Reno-NV-USA: American Society of Agricultural and Biological Engineers. 2009."},{"key":"2615_CR36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2001;46:3\u201326.","journal-title":"Adv Drug Deliv Rev"},{"key":"2615_CR37","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1021\/ci010366a","volume":"41","author":"TI Oprea","year":"2001","unstructured":"Oprea TI, Davis AM, Teague SJ, Leeson PD. Is there a difference between leads and drugs? A historical perspective. J Chem Inf Comput Sci. 2001;41:1308\u201315.","journal-title":"J Chem Inf Comput Sci"},{"issue":"3","key":"2615_CR38","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/cmdc.200700139","volume":"3","author":"R Brenk","year":"2008","unstructured":"Brenk R, Schipani A, James D, Krasowski A, Gilbert IH, Frearson J, Wyatt PG. Lessons learnt from assembling screening libraries for drug discovery for neglected diseases. Chem Med Chem. 2008;3(3):435\u201344.","journal-title":"Chem Med Chem"},{"issue":"6","key":"2615_CR39","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.chembiol.2010.05.013","volume":"17","author":"P Workman","year":"2010","unstructured":"Workman P, Collins I. Probing the probes: fitness factors for small molecule tools. Chem Biol. 2010;17(6):561\u201377.","journal-title":"Chem Biol"},{"key":"2615_CR40","first-page":"39","volume":"53","author":"JB Baell","year":"2013","unstructured":"Baell JB. Broad coverage of commercially available lead-like screening space with fewer than 350,000 compounds. Biochem Biophys Res Commun. 2013;53:39\u201355.","journal-title":"Biochem Biophys Res Commun"},{"key":"2615_CR41","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1023\/A:1008130001697","volume":"14","author":"TI Oprea","year":"2000","unstructured":"Oprea TI. Property distribution of drug-related chemical databases. J Comput Aided Mol Des. 2000;14:251\u201364.","journal-title":"J Comput Aided Mol Des"},{"key":"2615_CR42","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1021\/ci049714+","volume":"45","author":"JJ Irwin","year":"2005","unstructured":"Irwin JJ, Shoichet BK. ZINC\u2014a free database of commercially available compounds for virtual screening. J Chem Inf Model. 2005;45:177\u201382.","journal-title":"J Chem Inf Model"},{"key":"2615_CR43","doi-asserted-by":"publisher","first-page":"6752","DOI":"10.1021\/jm901241e","volume":"52","author":"F Lovering","year":"2009","unstructured":"Lovering F, Bikker J, Humblet C. Escape from flatland: increasing saturation as an approach to improving clinical success. J Med Chem. 2009;52:6752\u20136.","journal-title":"J Med Chem"},{"key":"2615_CR44","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1093\/bioinformatics\/bts186","volume":"28","author":"E Pihan","year":"2012","unstructured":"Pihan E, Colliandre L, Guichou JF, Douguet D. e-Drug 3D: 3D structure collections dedicated to drug repurposing and fragment-based drug design. Bioinformatics. 2012;28:1540\u20131.","journal-title":"Bioinformatics"},{"key":"2615_CR45","doi-asserted-by":"publisher","first-page":"5560","DOI":"10.1016\/j.bmcl.2009.08.045","volume":"19","author":"TW Johnson","year":"2009","unstructured":"Johnson TW, Dress KR, Edwards M. Using the golden triangle to optimize clearance and oral absorption. Bioorg Med Chem Lett. 2009;19:5560\u20134.","journal-title":"Bioorg Med Chem Lett"},{"issue":"5","key":"2615_CR46","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1023\/A:1015810312465","volume":"9","author":"RO Potts","year":"1992","unstructured":"Potts RO, Guy RH. Predicting skin permeability. Pharm Res. 1992;9(5):663\u20136.","journal-title":"Pharm Res"},{"key":"2615_CR47","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.addr.2012.05.001","volume":"65","author":"L Chen","year":"2013","unstructured":"Chen L, Han L, Lian G. Recent advances in predicting skin permeability of hydrophilic solutes. Adv Drug Deliv Rev. 2013;65:295\u2013305.","journal-title":"Adv Drug Deliv Rev"},{"key":"2615_CR48","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/0006-291X(91)91647-U","volume":"175","author":"P Artursson","year":"1991","unstructured":"Artursson P, Palm JE. Correlation between oral drug absorption in humans and apparent drug permeability coefficient in human intestinal epithelial (Caco-2) cells. Biochem Biophys Res Commun. 1991;175:880\u20135.","journal-title":"Biochem Biophys Res Commun"},{"key":"2615_CR49","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1023\/A:1011930411574","volume":"15","author":"M Yazdanian","year":"1998","unstructured":"Yazdanian M, Glynn SL, Wright JL, Hawi A. Correlating partitioning and Caco-2 cell permeability of structurally diverse small molecular weight compounds. Pharm Res. 1998;15:1490\u20134.","journal-title":"Pharm Res"},{"key":"2615_CR50","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1021\/jm001101a","volume":"44","author":"P Stenberg","year":"2001","unstructured":"Stenberg P, Norinder U, Luthman K, Artursson P. Experimental and computational screening models for the prediction of intestinal drug absorption. J Med Chem. 2001;44:1927\u201337.","journal-title":"J Med Chem"},{"key":"2615_CR51","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1021\/js9803205","volume":"88","author":"JD Irvine","year":"2000","unstructured":"Irvine JD, Takahashi L, Lockhart K, Cheong J, Tolan JW, Selick HE, et al. MDCK (Madin\u2013Darby canine kidney) cells: a tool for membrane permeability screening. J Pharm Sci. 2000;88:28\u201333.","journal-title":"J Pharm Sci"},{"key":"2615_CR52","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1021\/jm020017n","volume":"45","author":"DF Veber","year":"2002","unstructured":"Veber DF, Johnson SR, Cheng HY, Smith BR, Ward KW, Kopple KD. Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem. 2002;45:2615\u201323.","journal-title":"J Med Chem"},{"key":"2615_CR53","doi-asserted-by":"publisher","first-page":"3867","DOI":"10.1021\/jm000292e","volume":"43","author":"WJ Egan","year":"2000","unstructured":"Egan WJ, Merz KM Jr, Baldwin JJ. Prediction of drug absorption using multivariate statistics. J Med Chem. 2000;43:3867\u201377.","journal-title":"J Med Chem"},{"issue":"11","key":"2615_CR54","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1002\/cmdc.200600168","volume":"1","author":"M Lobell","year":"2006","unstructured":"Lobell M, Hendrix M, Hinzen B, Keldenich J, Meier H, Schmeck C, et al. In silico ADMET traffic lights as a tool for the prioritization of HTS hits. Chem Med Chem. 2006;1(11):1229\u201336.","journal-title":"Chem Med Chem"},{"key":"2615_CR55","doi-asserted-by":"publisher","first-page":"D668","DOI":"10.1093\/nar\/gkj067","volume":"34","author":"DS Wishart","year":"2006","unstructured":"Wishart DS, Knox C, Guo AC, Shrivastava S, Hassanali M, Stothard P, et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res. 2006;34:D668\u201372.","journal-title":"Nucleic Acids Res"},{"key":"2615_CR56","doi-asserted-by":"publisher","first-page":"4942","DOI":"10.1021\/jm9903996","volume":"42","author":"GW Bemis","year":"1999","unstructured":"Bemis GW, Murcko MA. Designing libraries with CNS activity. J Med Chem. 1999;42:4942\u201351.","journal-title":"J Med Chem"},{"issue":"1","key":"2615_CR57","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1023\/A:1008723723679","volume":"19","author":"RD Saiakhov","year":"2000","unstructured":"Saiakhov RD, Stefan LR, Klopman G. Multiple computer-automated structure evaluation model of the plasma protein binding affinity of diverse drugs. Perspect Drug Discov Des. 2000;19(1):133\u201355.","journal-title":"Perspect Drug Discov Des"},{"key":"2615_CR58","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/S0006-2952(02)01074-2","volume":"64","author":"NA Kratochwil","year":"2002","unstructured":"Kratochwil NA, Huber W, M\u00fcller F, Kansy M, Gerber PR. Predicting plasma protein binding of drugs: a new approach. Biochem Pharmacol. 2002;64:1355\u201374.","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"2615_CR59","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1111\/j.1745-7254.2005.00068.x","volume":"26","author":"X Ma","year":"2005","unstructured":"Ma X, Chen C, Yang J. Predictive model of blood-brain barrier penetration of organic compounds. Acta Pharmacol Sin. 2005;26(4):500\u201312.","journal-title":"Acta Pharmacol Sin"},{"key":"2615_CR60","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1023\/A:1016212804288","volume":"12","author":"GL Amidon","year":"1995","unstructured":"Amidon GL, Lennern\u00e4s H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 1995;12:413\u201320.","journal-title":"Pharm Res"},{"key":"2615_CR61","first-page":"12","volume":"1","author":"MP Wagh","year":"2010","unstructured":"Wagh MP, Patel JS. Biopharmaceutical classification system: scientific basis for biowaiver extensions. Int J Pharm Pharm Sci. 2010;1:12\u20139.","journal-title":"Int J Pharm Pharm Sci"},{"key":"2615_CR62","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1208\/s12248-008-9025-8","volume":"10","author":"KA Lentz","year":"2008","unstructured":"Lentz KA. Current methods for predicting human food effect. AAPS J. 2008;10:282\u20138.","journal-title":"AAPS J"},{"issue":"Suppl 2","key":"2615_CR63","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.1016\/S0928-0987(00)00181-0","volume":"11","author":"JB Dressman","year":"2000","unstructured":"Dressman JB, Reppas C. In vitro\u2013in vivo correlations for lipophilic, poorly water-soluble drugs. Eur J Pharm Sci. 2000;11(Suppl 2):S73\u201380.","journal-title":"Eur J Pharm Sci"},{"key":"2615_CR64","doi-asserted-by":"publisher","first-page":"3174","DOI":"10.1021\/ja01190a004","volume":"70","author":"LF Fieser","year":"1948","unstructured":"Fieser LF, Berliner E, Bondhus FJ, Chang FC, Dauben WG, Ettlinger MG, et al. Naphthoquinone antimalarials synthesis. J Am Chem Soc. 1948;70:3174\u2013215.","journal-title":"J Am Chem Soc"},{"key":"2615_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2011.08.032","volume":"420","author":"Y Kawabata","year":"2011","unstructured":"Kawabata Y, Wada K, Nakatani M, Yamada S, Onoue S. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications. Int J Pharm. 2011;420:1\u201310.","journal-title":"Int J Pharm"},{"key":"2615_CR66","first-page":"195727","volume":"2012","author":"KT Savjani","year":"2012","unstructured":"Savjani KT, Gajjar AK, Savjani JK. Drug solubility: importance and enhancement techniques. ISRN Pharm. 2012;2012:195727.","journal-title":"ISRN Pharm."},{"key":"2615_CR67","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/1475-2875-12-234","volume":"12","author":"DC Schuck","year":"2013","unstructured":"Schuck DC, Ferreira SB, Cruz LN, da Rocha DR, Moraes MS, Nakabashi M, et al. Biological evaluation of hydroxynaphthoquinones as anti-malarials. Malar J. 2013;12:234.","journal-title":"Malar J"},{"key":"2615_CR68","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.ejmech.2014.01.040","volume":"76","author":"TT Cloete","year":"2014","unstructured":"Cloete TT, de Kock C, Smith PJ, N\u2019Da DD. Synthesis, in vitro antiplasmodial activity and cytotoxicity of a series of artemisininetriazine hybrids and hybrid-dimers. Eur J Med Chem. 2014;76:470\u201381.","journal-title":"Eur J Med Chem"},{"key":"2615_CR69","doi-asserted-by":"publisher","first-page":"e0105217","DOI":"10.1371\/journal.pone.0105217","volume":"9","author":"MG Davan\u00e7o","year":"2014","unstructured":"Davan\u00e7o MG, Aguiar ACC, Santos LA, dos Padilha EC, Campos ML, Andrade CR, et al. Evaluation of antimalarial activity and toxicity of a new primaquine prodrug. PLoS ONE. 2014;9:e0105217.","journal-title":"PLoS ONE"},{"key":"2615_CR70","doi-asserted-by":"publisher","first-page":"5898","DOI":"10.3390\/molecules19055898","volume":"19","author":"CBS Oliveira","year":"2014","unstructured":"Oliveira CBS, Meurer YSR, Oliveria MG, Medeiros WMTQ, Silva FON, Brito ACF, et al. Comparative study on the antioxidant and anti-toxoplasma activities of vanillin and its resorcinarene derivative. Molecules. 2014;19:5898\u2013912.","journal-title":"Molecules"},{"key":"2615_CR71","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.freeradbiomed.2008.06.025","volume":"45","author":"J Gruszka","year":"2008","unstructured":"Gruszka J, Pawlak A, Kruk J. Tocochromanols, plastoquinol, and other biological prenyllipids as singlet oxygen quenchers\u2014determination of singlet oxygen quenching rate constants and oxidation products. Free Radic Biol Med. 2008;45:920\u20138.","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"2615_CR72","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1128\/AAC.01820-10","volume":"55","author":"FM Jord\u00e3o","year":"2011","unstructured":"Jord\u00e3o FM, Saito AY, Miguel DC, Peres VJ, Kimura EA, Katzin AM. In vitro and in vivo antiplasmodial activities of risedronate and its interference with protein prenylation in Plasmodium falciparum. Antimicrob Agents Chemother. 2011;55(5):2026\u201331.","journal-title":"Antimicrob Agents Chemother"},{"key":"2615_CR73","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1128\/AAC.46.5.1163-1173.2002","volume":"46","author":"AL Baggish","year":"2002","unstructured":"Baggish AL, Hill DR. Antiparasitic agent atovaquone. Antimicrob Agents Chemother. 2002;46:1163\u201373.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-018-2615-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12936-018-2615-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-018-2615-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T19:05:04Z","timestamp":1576695904000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-018-2615-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2615"],"URL":"https:\/\/doi.org\/10.1186\/s12936-018-2615-8","relation":{},"ISSN":["1475-2875"],"issn-type":[{"type":"electronic","value":"1475-2875"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"19 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"482"}}